Corteva leads €8.8M Series A for Resurrect Bio to transform crop resilience

London-based Resurrect Bio has successfully closed its Series A funding round, securing a total of €8.8 million to advance its agricultural biotechnology platform. This oversubscribed round was led by Corteva, a global leader in agriculture, through its specialized Corteva Catalyst investment arm. The initial close of €6.8 million in February 2026 was bolstered by additional capital, reflecting strong institutional confidence in the startup's approach to crop disease…